Impact Factor
3.84
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
3.71
1,433 total citations
h5-index
48
h5 depth signal
Cited share
79.6%
343 of 431
Total citations
1,433
Citation footprint
Metric signal
4.06
External metric anchor
Self-citation
4.3%
62 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
546
France
234
United Kingdom
219
China
183
Germany
168
Citing Fields of Research
Immunology
1,061
Hematology
602
Auto-Inflammatory Disorders
359
Genetics & Genomics
165
Virology
123
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
4,581
Articles tracked across the journal lifetime
Indexed publication set
431
343 cited publications
Last 12 months
140
11.7 publications/month
Open access share
100.0%
140 OA publications in the last year
Leading citing country
United States
546 citing publications
Leading citing field
Immunology
1,061 citing publications
Latest tracked publication
19 October 2026
10 recent records available
Coverage & Indexing History
v1n1,Jan. 1981-
v1n1,Jan. 1981-
Active Coverage
Research Focus & Classification
Indexed Subjects
Immunology
Hematology
Auto-Inflammatory Disorders
Broad Categories
Allergy and Immunology
Hematology
Immunology
Auto-Inflammatory Disorders
Musculoskeletal Disorders
Fungal Pathogenesis
Virology
MeSH Descriptors
Allergy and Immunology
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1007/s10875-026-02081-3
Open DOI
A multi-composite disease activity score (NFKB1-DAS) for NFKB1 insufficiency
NFKB1 encodes the p105/p50 NF-κB1 transcription factor. Heterozygous mutations in NFKB1 may lead to NFKB1 insufficiency affecting multiple organ systems. This study aimed to develop an NFKB1 -Disease-Activity-Score ( NFKB1 -DAS), serving...
02
03
04
DOI 10.1007/s10875-026-02085-z
Open DOI
Humoral Immunity and Variant Cross-Reactivity Following Asymptomatic and Symptomatic SARS-CoV-2 Infection and Vaccination in Young Adults (The ACE Cohort)
Purpose: Asymptomatic SARS-CoV-2 infection was a driving force of the COVID-19 pandemic, acting as a silent transmitter of the virus. The question of whether asymptomatic immunity differs from symptomatic immunity remains, as existing st...
05
DOI 10.1007/s10875-026-02069-z
Open DOI
Delayed Reconstitution of Thymopoiesis After a Thymus Transplant
06
DOI 10.1007/s10875-026-02079-x
Open DOI
X-Linked Agammaglobulinemia with De novo BTK Mutations in Chinese Children: A Case Report and Literature Review
07
DOI 10.1007/s10875-026-02078-y
Open DOI
Correction to: Cancer Trends in Inborn Errors of Immunity: A Systematic Review and Meta‑Analysis
08
DOI 10.1007/s10875-026-02077-z
Open DOI
Genetic and Clinical Spectrum of Inborn Errors of Immunity in the Pakistani Population: A Systematic Review
Background: Inborn errors of immunity (IEIs), historically termed primary immunodeficiencies (PID), are a broad group of rare inherited diseases caused by genetic variants that impair the development or functioning of the immune system. ...
09
DOI 10.1007/s10875-026-02076-0
Open DOI
Hepatic Candida albicans Infection in a Child With CARD9 Deficiency: A Case Report and Literature Review
10
Bibliographical & Catalog Notes
Title from cover.
Also issued online.
(1989)19890818 Notice not published Printed on acid-free paper